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Abstract 
 
Background: Detection of frequency of neuropathy in 
patients with chronic renal failure by utilizing nerve 
conduction studies (NCS) 
Methods: In this cross sectional comparative study, 
thirty  patients with chronic renal failure, of at least three 
months duration were included. Patients were further 
segregated into two groups. In group I twenty patients on 
regular hemodialysis and in group II ten patients with end 
stage renal failure waiting for hemodialysis were included. 
Motor nerve conduction studies  were done by testing 
median nerve and  peroneal nerve, in upper and lower 
limbs respectively. Parameters of motor conduction studies 
checked were proximal and distal motor latencies, 
amplitudes and conduction velocities. 
Results:  In group I, 93% of patients and in group II, 
87% of patients showed altered motor nerve conduction 
parameters. 
Conclusions There is predominantly distal nerve 
dysfunction and peripheral nerves of lower limb are 
affected more than upper limb. Sub clinical neuropathies 
can be detected by nerve conduction  studies. . 
Key Words: Nerve conduction studies, peripheral 
neuropathy, chronic renal failure 
 
Introduction 
 
Chronic Renal Failure (CRF) is a functional 
diagnosis characterized by progressive and 
irreversible decline in glomerular filtration rate (GFR).1 
It is characterized by an increasing inability to 
maintain normal low levels of products of protein 
metabolism (such as urea), normal blood pressure, 
hematocrit, sodium, water, potassium and acid base 
balance.Reduction in renal mass causes structural and 
functional hypertrophy of surviving neurons.2 
CRF patients usually pass through four 
overlapping phases. These phases are decreased renal 
reserve, mild renal insufficiency, overt renal failure 
and end stage renal failure. Polyneuropathy has been 
recognized as the most common complication of end 
stage renal failure. Uraemic neuropathy presents as 
painless, progressive, symmetrical, sensorimotor 
polyneuropathy.There is segmental demyelination and 
axonal degeneration in peripheral nerves.3 
A clinician faces two problems while 
managing patients with peripheral neuropathy. These 
are establishing the existence of disease of peripheral 
nervous system and ascertaining its nature. It is 
necessary to perform a number of procedures such as 
biochemical tests, CSF examination, needle 
examination of muscle, nerve muscle biopsy and 
electrophysiological studies. Out of all the above 
mentioned investigations, nerve conduction studies 
have been found to be the most sensitive detector of 
neuropathy. This non-invasive procedure provides a 
definite evidence of sub clinical neuropathy and often 
precedes either signs or symptoms of uraemia.4  
Usual parameters of electrophysiological 
studies include latency, amplitude, and duration of 
conduction. Onset latency shows the conduction time 
of fastest fibers.It is increased in uraemia. Conduction 
velocity has remained one of the best measurements of 
peripheral nerve function. Amplitude of compound 
muscle action potential depends upon number of 
active firing axons. When toxin enters at endoneural 
space and causes axonal damage, this results in 
considerable reduction of amplitude. 5 
Uraemic patients need close monitoring. 
Nerve conduction studies fulfill this purpose. This 
neuropathy is difficult to revert , but  hemodialysis, 
peritoneal dialysis and successful transplantation 
result in improvement  of different neurological 
measures. 6,7    
 
Patients and Methods 
 
A total of consecutive 30 patients fulfilling the 
criteria of CRF were selected by purposive sampling 
with 10 normal control subjects. Written informed 
consent was obtained from all subjects and controls. 
Study was conducted in Medical unit II, Sir Ganga 
Ram Hospital, Lahore. Uraemic patients of at least 3 
months duration with glomerular filtration rate (GFR) 
<30ml/min were included in the study. Patients with 
diabetes mellitus, paraplegia, systemic lupus 
erythematosis, polyarteritis nodosa, alcoholism and 
drug induced neuropathies were excluded. 
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Their ages ranged from 25-42 years. Patients 
were segregated in two groups. In Group I twenty 
patients receiving regular hemodialysis were included. 
In Group II ten patients with end stage renal failure 
not dialyzed yet were included. 
Motor Nerve Conduction Study: Conduction 
characteristics of motor nerve fibers were assessed by 
studying compound evoked potentials recorded from 
the muscles. Use of standard methods allows precise 
lesion localization and accurate characterization of 
peripheral nerve functions. Belly tendon method was 
used in this study 8.  Motor nerve conduction 
parameters of median nerve in upper limb and 
common peroneal nerve in lower limb were assessed. 
Duration of stimulation was 0.5 to 1.0 ms. Rate 
of stimulation was 30 to 50/sec. Intensity was 
gradually increased to get maximum response. Then 
20 to 30 percent further increase was done. This 
supramaximal stimulation ensures activation of all the 
nerve fibers. Evoked motor response is called a 
compound muscle action potential (CMAP).The 
stimulation was given at two points along the course 
of motor nerve. Following parameters of CMAP were 
measured. 
Proximal motor latency(ms) 
Distal motor latency (ms) 
Amplitude peak to peak(mv) 
Conduction velocity  (m/s) = Distance (mm) between 
proximal and distal stimulating sites                
 Proximal  latency – distal latency 
 
Statistical Analysis: 
The significance of differences between means 
of measurements of two groups was determined by 
student t test. Correlation between two groups 
parameters were sought with linear regression 
analysis by the least square method. A probability 
value <0.05 was considered statistically significant. 
Results were expressed as mean ± standard error of 
mean.  
 
Results 
 
In group I, abnormalities of motor conduction 
parameters were demonstrated in 93% of the patients. 
Median nerve proximal and distal motor latencies 
were prolonged in 79% of the patients. Amplitude of 
latencies was decreased in 86% of the patients. 
Conduction velocity was decreased in 80% of the 
patients (Table-1). Peroneal nerve proximal & distal 
motor latencies were prolonged in 78% of patients. 
Amplitudes were decreased in 87% of the patients. 
Conduction velocity was decreased in 82% of the 
patients (Table 2.)  
In group II median nerve proximal and distal 
motor latencies were prolonged in 71% of patients. 
Amplitudes were decreased in 80% of the patients. 
Conduction velocity was decreased in 82% of the 
patients (Table 3). 
Peroneal nerve proximal and distal motor 
latencies were prolonged in 78% of the patients in 
group II. Amplitude of latencies was decreased in 80% 
of the patients. Conduction velocity was decreased in 
80% of the patients (Table 4). 
 
Discussion 
 
Uraemic neuropathy is a common 
complication of chronic renal failure. Usually it is 
distal, symmetrical mixed polyneuropathy or central 
to peripheral axonopathy.9 The present study 
investigated excitability properties of upper & lower 
limb motor axons in CRF patients .Previous studies 
have demonstrated prevalence rates of neuropathy 
from 60 to 100% depending on the choice of nerve 
segment, the indices measured, and number of nerves 
studied. 10,11 The slowing of MNCV in upper & lower 
limb confirmed the previous observations of distal 
polyneuropathy. It is seen in many CRF patients, with 
end stage renal failure or those who undergo long 
term hemodialysis. 12  
The electrophysiological findings confirmed 
the result of previous study that  peripheral nerves are 
more severely affected in lower limb than in upper 
limb.13 While there was no clinical evidence of 
peripheral neuropathy in some patients motor nerve 
conduction studies disclosed definite evidence of sub 
clinical neuropathy as previous studies have 
demonstrated. 14 The rate of neuropathy in the present 
study was 93% in group 1 & 91% in group 2 in keeping 
with the previous studies of uraemic neuropathy 
which have demonstrated similarly high rates of 
neuropathy. There was significant decrease in 
amplitude of peroneal nerve CMAP. These 
electrophysiological findings are in partial agreement 
with those obtained by Arum.2 The observations of 
predominantly distal nerve dysfunction in some CRF 
patients agrees with the findings of Makkar.4  
There was no significant difference of 
conduction parameters in these two groups which 
provide a contrast to Arum2 who found a clear 
improvement in excitability parameters following 
dialysis.  These studies serve the purpose of detection 
of not only the presence and severity of peripheral 
nerve dysfunction but also its precise localization and 
pathophysiology.15 
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Table 1: Median Nerve Motor studies in upper limb in Group I 
GROUPS Proximal motor latency (ms) Amplitude (mv) 
Distal motor 
latency (ms) Amplitude (mv) 
Velocity 
(m/s) 
Control      
Mean 3.2 13.7 8.3 13.2 53.17 
SEM 0.1 0.2 0.2 0.4 2.2 
p value <0.01 <0.01 <0.01 <0.01 <0.01 
Experimental      
Mean 4.9 8.9 11.6 8.4 39.14 
SEM 0.009 0.23 0.18 0.13 0.9 
 
Table 2: Peroneal  Nerve Motor studies in lower limb in Group I 
GROUPS Proximal motor latency (ms) Amplitude (mv) 
Distal motor 
latency (ms) 
Amplitude 
(mv) 
Velocity 
(m/s) 
Control      
Mean 3.3 13.3 9.4 13.0 56.3 
SEM 0.1 0.2 0.1 0.3 1.7 
P value <0.01 <0.01 <0.01 <0.01 0.007 
Experimental      
Mean 8.1 3.9 17.4 3.9 37.9 
SEM 0.2 0.3 0.3 0.3 1.3 
 
Table 3: Median Nerve Motor studies in upper limb Group II 
GROUPS Proximal motor latency (ms) 
Amplitude 
(mv) 
Distal motor 
latency (ms) 
Amplitude 
(mv) Velocity (m/s) 
Control      
Mean 3.2 13.7 8.3 13.2 53.17 
SEM 0.1 0.2 0.2 0.4 2.2 
p value <0.01 <0.01 <0.01 <0.01 0.007 
Experimental      
Mean 4.8 9.3 11.2 8.1 40.9 
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SEM 0.17 0.4 0.2 0.1 1.4 
 
Table 4: Peroneal  Nerve Motor studies in lower limb Group II 
GROUPS Proximal motor latency (ms) 
Amplitude 
(mv) 
Distal motor 
latency (ms) 
Amplitude 
(mv) Velocity (m/s) 
Control      
Mean 3.3 13.3 9.4 13.0 56.3 
SEM 0.1 0.2 0.1 0.3 1.7 
p value <0.01 <0.01 <0.01 <0.01 0.007 
Experimental      
Mean 8.8 3.4 17.9 4.5 38.5 
SEM 0.4 0.1 0.8 1.1 2.8 
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